Vietnam Report JSC officially announced the list of the Top Reputable Companies in the Pharmaceutical, Medical Equipment, and Healthcare sectors for 2024. The ranking is based on three key criteria: financial capacity, media reputation, and surveys conducted in October and November 2024.

On November 22, 2024, Vietnam Report JSC officially announced the list of the Top Reputable Companies in the Pharmaceutical, Medical Equipment, and Healthcare sectors for 2024. This ranking was developed based on three main criteria:

• • Financial Capacity: Evaluated based on the latest annual financial reports.
  • Media Reputation: Assessed through Media Coding, analyzing articles about the company on influential media channels.
  • Stakeholder Surveys: Conducted from October to November 2024.

The 2024 rankings are divided into four groups of reputable companies:

1. Top 10 Pharmaceutical Manufacturers

DHG Pharma JSC (CTCP Dược Hậu Giang) and Traphaco maintain their leading positions. Imexpharm Pharmaceutical JSC climbed to 3rd place compared to 2023. New entries this year include Hatay Pharmaceutical JSC and Rohto-Mentholatum (Vietnam).

2. Top 10 Pharmaceutical Distributors

3. Top 10 Medical Equipment & Healthcare Companies

The Pharmaceutical & Medical Equipment sector plays a crucial role in ensuring timely and safe access to medical products, bringing advanced medical and technological progress to communities. However, after a promising 2023, the sector slowed in the first 10 months of 2024, especially during Q1 and Q2. According to Vietnam Report, the percentage of companies experiencing a decline in business compared to the high baseline of 2023 increased. While revenue remained relatively stable year-on-year, the proportion of companies reporting profit declines rose significantly (from 21.1% to 37.5 %).

4. Top 5 Traditional Medicine Companies

Positive Outlook for the Future:

• • Despite challenges, the final months of the year are expected to show a more optimistic picture. Business leaders anticipate Q4 to be the most dynamic quarter, especially for healthcare products, as demand rises during seasonal transitions and the occurrence of diseases like dengue fever, viral infections, and flu…
  • Optimism remains strong among businesses regarding the outlook for 2025. According to a survey by Vietnam Report, 66.6% of enterprises expressed confidence in market growth, only 13.4% anticipated facing greater challenges, while 20.0% believed the market would remain stable with minimal fluctuations compared to 2024.
  • The hospital drug distribution channel (ETC), which dominates the industry’s revenue, is expected to maintain its position and see further growth, supported by universal health insurance policies and more flexible hospital drug bidding regulations. Additionally, there is increasing demand for specialized pharmaceutical products, particularly rare drugs, biologics, and treatments for critical illnesses. Meanwhile, the pharmacy distribution channel (OTC), although showing modest revenue growth over the past.

Reference

https://vietnamreport.net.vn/Top-10-Cong-ty-uy-tin-nganh-Duoc–Thiet-bi-y-te-Cham-soc-suc-khoe-nam-2024-11012-1067.html

Read more on the TOP 20 Companies with the Highest Global Sales in 2023 at SEN Pharma’s website